Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.11.22 extracted from

  • Wang, H.; Xu, Y.; Fang, Z.; Chen, S.; Balk, S.P.; Yuan, X.
    Doxycycline regulated induction of AKT in murine prostate drives proliferation independently of p27 cyclin dependent kinase inhibitor downregulation (2012), PLoS ONE, 7, e41330.
    View publication on PubMedView publication on EuropePMC

Activating Compound

Activating Compound Comment Organism Structure
cyclin T CDK9 activating partner cyclin T1 Homo sapiens

Application

Application Comment Organism
medicine CDK9 represents a novel therapeutic target in chronic inflammatory diseases such as Rheumatoid Arthritis Homo sapiens

Inhibitors

Inhibitors Comment Organism Structure
flavopiridol a potent CDK9 inhibitor Homo sapiens

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
ATP + RNA polymerase II C-terminal domain protein Homo sapiens
-
ADP + RNA polymerase II C-terminal domain phosphoprotein
-
?

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
neutrophil CDK 7 and CDK9 are the predominant CDKs present, with CDK5 present only at a very low level. CDK9 activity and the expression of its activating partner cyclin T1 both declined as neutrophils aged and entered apoptosis spontaneously. No cell cycle-dependent CDKs, CDK1, CDK2, CDK4 or CDK6, in neutrophils Homo sapiens
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
ATP + RNA polymerase II C-terminal domain protein
-
Homo sapiens ADP + RNA polymerase II C-terminal domain phosphoprotein
-
?

Synonyms

Synonyms Comment Organism
CDK
-
Homo sapiens
Cdk5
-
Homo sapiens
cdk7
-
Homo sapiens
CDK9
-
Homo sapiens
p27 cyclin dependent kinase
-
Homo sapiens

General Information

General Information Comment Organism
additional information inhibition of CDK9 with flavopiridol does not result in loss of Bcl2A Homo sapiens
physiological function CDK9 is a component of the P-TEFb complex involved in transcriptional regulation. CDK9 activity is a key regulator of neutrophil lifespan, preventing apoptosis by maintaining levels of short lived anti-apoptotic proteins such as Mcl-1. Upon association with its activating partner cyclin T1, CDK9 forms P-TEFb, a general transcription factor responsible for phosphorylating the C-terminal domain of RNA polymerase II Homo sapiens